![]() |
|
#1
|
|||
|
|||
|
* To discontinue development after independent adjudicatio**f major adverse cardiovascular events confirmed an increasedrisk of stroke ??????? ??????: BRIEF-Merck provides update on odanacatib development program || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|